questionsmedicales.fr
Qualité, accès, évaluation des soins de santé
Prestations des soins de santé
Attitude envers la santé
Adhésion et observance thérapeutiques
Acceptation des soins par les patients
Observance par le patient
Adhésion au traitement médicamenteux
Adhésion au traitement médicamenteux : Questions médicales fréquentes
Diagnostic
5
Adhésion au traitement
Évaluation de la santé
Tests de laboratoire
Adhésion au traitement
Symptômes cliniques
Adhésion au traitement
Évaluation de la santé
Adhésion au traitement
Auto-évaluation
Adhésion au traitement
Symptômes
5
Symptômes cliniques
Adhésion au traitement
Symptômes cliniques
Adhésion au traitement
Effets indésirables
Adhésion au traitement
Troubles psychologiques
Adhésion au traitement
Sevrage
Adhésion au traitement
Prévention
5
Prévention
Adhésion au traitement
Communication médicale
Adhésion au traitement
Rappels de médicaments
Adhésion au traitement
Soutien familial
Adhésion au traitement
Groupes de soutien
Adhésion au traitement
Traitements
5
Traitements médicamenteux
Adhésion au traitement
Conseils médicaux
Adhésion au traitement
Thérapies combinées
Adhésion au traitement
Technologie de la santé
Adhésion au traitement
Éducation des patients
Adhésion au traitement
Complications
5
Complications médicales
Adhésion au traitement
Progression de la maladie
Adhésion au traitement
Troubles psychologiques
Adhésion au traitement
Résistance aux médicaments
Adhésion au traitement
Coûts des soins de santé
Adhésion au traitement
Facteurs de risque
5
Facteurs de risque
Adhésion au traitement
Éducation
Adhésion au traitement
Santé mentale
Adhésion au traitement
Soutien social
Adhésion au traitement
Croyances culturelles
Adhésion au traitement
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Adhésion au traitement médicamenteux : Questions médicales les plus fréquentes",
"headline": "Adhésion au traitement médicamenteux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Adhésion au traitement médicamenteux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-29",
"dateModified": "2026-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Adhésion au traitement médicamenteux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Observance par le patient",
"url": "https://questionsmedicales.fr/mesh/D010349",
"about": {
"@type": "MedicalCondition",
"name": "Observance par le patient",
"code": {
"@type": "MedicalCode",
"code": "D010349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.300.150.800.500.600"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie sous observation directe",
"alternateName": "Directly Observed Therapy",
"url": "https://questionsmedicales.fr/mesh/D023801",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie sous observation directe",
"code": {
"@type": "MedicalCode",
"code": "D023801",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.300.150.800.500.600.500.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Adhésion au traitement médicamenteux",
"alternateName": "Medication Adherence",
"code": {
"@type": "MedicalCode",
"code": "D055118",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Paula Anne Newman-Casey",
"url": "https://questionsmedicales.fr/author/Paula%20Anne%20Newman-Casey",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan. Electronic address: panewman@umich.edu."
}
},
{
"@type": "Person",
"name": "Michal Shani",
"url": "https://questionsmedicales.fr/author/Michal%20Shani",
"affiliation": {
"@type": "Organization",
"name": "Department of Family Medicine, Central District, Clalit Health Services, Tel Aviv, Israel."
}
},
{
"@type": "Person",
"name": "Alex Lustman",
"url": "https://questionsmedicales.fr/author/Alex%20Lustman",
"affiliation": {
"@type": "Organization",
"name": "Department of Family Medicine, Central District, Clalit Health Services, Tel Aviv, Israel."
}
},
{
"@type": "Person",
"name": "Tino Prell",
"url": "https://questionsmedicales.fr/author/Tino%20Prell",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Jena University Hospital, Jena, Germany."
}
},
{
"@type": "Person",
"name": "Julian Grosskreutz",
"url": "https://questionsmedicales.fr/author/Julian%20Grosskreutz",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Jena University Hospital, Jena, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Schizophrenia and medication adherence: Associated factors.",
"datePublished": "2024-01-25",
"url": "https://questionsmedicales.fr/article/38734454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.apnu.2024.01.015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Medication adherence in youths with CKD: habits for success.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37306720",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00467-023-05976-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Spanish translation of the ABC taxonomy for medication adherence.",
"datePublished": "2023-05-19",
"url": "https://questionsmedicales.fr/article/37321926",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.sapharm.2023.05.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adherence to antiseizure medications in an underserved population with epilepsy.",
"datePublished": "2023-11-20",
"url": "https://questionsmedicales.fr/article/37988904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.yebeh.2023.109484"
}
},
{
"@type": "ScholarlyArticle",
"name": "Osteoporosis medication adherence tools: a systematic review.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37286664",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00198-023-06789-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Qualité, accès, évaluation des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D017530"
},
{
"@type": "ListItem",
"position": 3,
"name": "Prestations des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D003695"
},
{
"@type": "ListItem",
"position": 4,
"name": "Attitude envers la santé",
"item": "https://questionsmedicales.fr/mesh/D001294"
},
{
"@type": "ListItem",
"position": 5,
"name": "Adhésion et observance thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D000074822"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acceptation des soins par les patients",
"item": "https://questionsmedicales.fr/mesh/D010342"
},
{
"@type": "ListItem",
"position": 7,
"name": "Observance par le patient",
"item": "https://questionsmedicales.fr/mesh/D010349"
},
{
"@type": "ListItem",
"position": 8,
"name": "Adhésion au traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D055118"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Adhésion au traitement médicamenteux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Adhésion au traitement médicamenteux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Adhésion au traitement médicamenteux",
"description": "Comment évaluer l'adhésion au traitement ?\nQuels tests peuvent indiquer une mauvaise adhésion ?\nQuels signes cliniques montrent une non-adhésion ?\nComment les professionnels évaluent-ils l'adhésion ?\nQuelles sont les méthodes d'auto-évaluation ?",
"url": "https://questionsmedicales.fr/mesh/D055118#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Adhésion au traitement médicamenteux",
"description": "Quels symptômes indiquent une mauvaise adhésion ?\nComment la non-adhésion affecte-t-elle les symptômes ?\nLes effets secondaires influencent-ils l'adhésion ?\nQuels symptômes psychologiques peuvent apparaître ?\nLes symptômes de sevrage affectent-ils l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Adhésion au traitement médicamenteux",
"description": "Comment prévenir la non-adhésion au traitement ?\nQuel rôle joue la communication médecin-patient ?\nLes rappels de médicaments sont-ils efficaces ?\nComment impliquer la famille dans l'adhésion ?\nLes groupes de soutien aident-ils l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Adhésion au traitement médicamenteux",
"description": "Quels traitements améliorent l'adhésion ?\nComment les professionnels aident-ils à l'adhésion ?\nLes thérapies combinées influencent-elles l'adhésion ?\nQuel rôle jouent les applications de santé ?\nLes programmes d'éducation améliorent-ils l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Adhésion au traitement médicamenteux",
"description": "Quelles complications résultent d'une mauvaise adhésion ?\nComment la non-adhésion affecte-t-elle la maladie ?\nLes complications psychologiques sont-elles fréquentes ?\nLa résistance aux médicaments est-elle liée à l'adhésion ?\nLes complications financières influencent-elles l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Adhésion au traitement médicamenteux",
"description": "Quels facteurs augmentent le risque de non-adhésion ?\nLe niveau d'éducation influence-t-il l'adhésion ?\nLes problèmes de santé mentale affectent-ils l'adhésion ?\nLe soutien social joue-t-il un rôle ?\nLes croyances culturelles influencent-elles l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'adhésion au traitement ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'adhésion peut être évaluée par des questionnaires, des entretiens et des mesures de médicaments."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent indiquer une mauvaise adhésion ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de niveaux sanguins de médicaments peuvent révéler une non-adhésion."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques montrent une non-adhésion ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exacerbations de la maladie ou des hospitalisations fréquentes peuvent indiquer une non-adhésion."
}
},
{
"@type": "Question",
"name": "Comment les professionnels évaluent-ils l'adhésion ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils utilisent des outils comme les journaux de médication et les entretiens avec les patients."
}
},
{
"@type": "Question",
"name": "Quelles sont les méthodes d'auto-évaluation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent utiliser des applications ou des journaux pour suivre leur prise de médicaments."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une mauvaise adhésion ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes persistants ou aggravés peuvent signaler une mauvaise adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Comment la non-adhésion affecte-t-elle les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une aggravation des symptômes et une détérioration de la santé globale."
}
},
{
"@type": "Question",
"name": "Les effets secondaires influencent-ils l'adhésion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent décourager les patients de suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes psychologiques peuvent apparaître ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété et la dépression peuvent résulter d'une mauvaise adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Les symptômes de sevrage affectent-ils l'adhésion ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes de sevrage peuvent inciter les patients à ne pas suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir la non-adhésion au traitement ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, le soutien psychologique et des suivis réguliers."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la communication médecin-patient ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne communication favorise la compréhension et l'adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Les rappels de médicaments sont-ils efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les rappels par SMS ou applications augmentent l'adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Comment impliquer la famille dans l'adhésion ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La famille peut soutenir le patient en l'aidant à suivre son traitement et à gérer les effets secondaires."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien aident-ils l'adhésion ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un environnement motivant et des conseils pratiques."
}
},
{
"@type": "Question",
"name": "Quels traitements améliorent l'adhésion ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements simplifiés et les médicaments à dose unique par jour favorisent l'adhésion."
}
},
{
"@type": "Question",
"name": "Comment les professionnels aident-ils à l'adhésion ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils fournissent des conseils, des rappels et des outils de suivi pour améliorer l'adhésion."
}
},
{
"@type": "Question",
"name": "Les thérapies combinées influencent-elles l'adhésion ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies combinées peuvent compliquer l'adhésion si elles ne sont pas bien gérées."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les applications de santé ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les applications aident à rappeler aux patients de prendre leurs médicaments et à suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Les programmes d'éducation améliorent-ils l'adhésion ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation des patients sur leur maladie et leur traitement favorise l'adhésion."
}
},
{
"@type": "Question",
"name": "Quelles complications résultent d'une mauvaise adhésion ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des hospitalisations, des rechutes et des complications graves."
}
},
{
"@type": "Question",
"name": "Comment la non-adhésion affecte-t-elle la maladie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une progression de la maladie et une réponse moins efficace au traitement."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la non-adhésion peut entraîner des troubles psychologiques comme l'anxiété."
}
},
{
"@type": "Question",
"name": "La résistance aux médicaments est-elle liée à l'adhésion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise adhésion peut contribuer à la résistance aux médicaments, surtout en infectiologie."
}
},
{
"@type": "Question",
"name": "Les complications financières influencent-elles l'adhésion ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les coûts des médicaments peuvent dissuader les patients de suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de non-adhésion ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la complexité du traitement, les effets secondaires et le manque de soutien."
}
},
{
"@type": "Question",
"name": "Le niveau d'éducation influence-t-il l'adhésion ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un faible niveau d'éducation peut réduire la compréhension du traitement et l'adhésion."
}
},
{
"@type": "Question",
"name": "Les problèmes de santé mentale affectent-ils l'adhésion ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles mentaux peuvent diminuer la capacité d'un patient à suivre son traitement."
}
},
{
"@type": "Question",
"name": "Le soutien social joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soutien social peut améliorer l'adhésion au traitement et la gestion de la maladie."
}
},
{
"@type": "Question",
"name": "Les croyances culturelles influencent-elles l'adhésion ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines croyances culturelles peuvent affecter la perception et l'adhésion au traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/03/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan. Electronic address: panewman@umich.edu.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Family Medicine, Central District, Clalit Health Services, Tel Aviv, Israel.
Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Community Division, Clalit Health Services Headquarters, Tel Aviv, Israel.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Family Medicine, Central District, Clalit Health Services, Tel Aviv, Israel.
Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Community Division, Clalit Health Services Headquarters, Tel Aviv, Israel.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Jena University Hospital, Jena, Germany.
Center for Healthy Aging, Jena University Hospital, Jena, Germany.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Jena University Hospital, Jena, Germany.
Center for Healthy Aging, Jena University Hospital, Jena, Germany.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Jena University Hospital, Jena, Germany.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Jena University Hospital, Jena, Germany.
Center for Healthy Aging, Jena University Hospital, Jena, Germany.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Jena University Hospital, Jena, Germany.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Nivel, P.O. Box 1568, 3500, Utrecht, BN, The Netherlands.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Nivel, P.O. Box 1568, 3500, Utrecht, BN, The Netherlands.
Department of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Groningen, University of Groningen, Groningen, The Netherlands.
Publications dans "Adhésion au traitement médicamenteux" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan.
Publications dans "Adhésion au traitement médicamenteux" :
1 publication dans cette catégorie
Affiliations :
Iranian Epilepsy Association, Tehran, Iran.
Sudan League of Epilepsy and Neurology (SLeN), Khartoum, Sudan.
Nepal Interest Group of Epilepsy and Neurology (NiGEN), Kathmandu, Nepal.
Pôle Universitaire Euclide Intergovernmental UN Treaty 49006/49007, Bangui, Central African Republic.
Publications dans "Adhésion au traitement médicamenteux" :
1 publication dans cette catégorie
Affiliations :
Iranian Research Centre on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Department of Health Education and Promotion, Tabriz University of Medical Sciences, Tabriz, Iran.
Publications dans "Adhésion au traitement médicamenteux" :
1 publication dans cette catégorie
Affiliations :
Iranian Research Centre on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Publications dans "Adhésion au traitement médicamenteux" :
1 publication dans cette catégorie
Affiliations :
Iranian Research Centre on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Publications dans "Adhésion au traitement médicamenteux" :
1 publication dans cette catégorie
Affiliations :
Iranian Research Centre on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Publications dans "Adhésion au traitement médicamenteux" :
1 publication dans cette catégorie
Affiliations :
Iranian Epilepsy Association, Tehran, Iran.
Publications dans "Adhésion au traitement médicamenteux" :
1 publication dans cette catégorie
Affiliations :
Iranian Epilepsy Association, Tehran, Iran.
Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Adhésion au traitement médicamenteux" :
Schizophrenia is a chronic condition that requiring maintenance treatment with antipsychotic medication. Medication adherence is essential to improve the symptoms of this health problem reduce relapse...
This study was conducted to determine factors associated with medication adherence in individuals diagnosed with schizophrenia....
A descriptive correlational research design was used. The study was completed with a total of 162 participants diagnosed with schizophrenia, between February-June 2021, at a Community Mental Health Ce...
The mean medication adherence score of individual diagnosed with schizophrenia indicated that more than half of the participants (52 %) had poor medication adherence. In individual diagnosed with schi...
Medication adherence in individuals with diagnosed schizophrenia may be multifactorial. Mental health professionals should consider associated factors and implement a personalized treatment plan in th...
Poor adherence habits are key contributors to nonadherence but there are few clinically feasible methods for evaluating adherence habits, particularly for youths with chronic kidney disease (CKD). Thi...
Participants (ages 11-21 years) were recruited from a pediatric nephrology clinic as part of a larger study. Participants' daily objective antihypertensive medication adherence was measured with an el...
Clear qualitative differences emerged in how participants with high-medium adherence (80-100%) discussed adherence habits compared to participants with low adherence (0-79%). Participants with high-me...
Evaluating patient responses to questions about adherence habits may uncover challenges with adherence habit formation, provide direction for habit-strengthening intervention focused on developing aut...
NCT03651596. A higher resolution version of the Graphical abstract is available as Supplementary information....
The Ascertaining Barriers to Compliance (ABC) taxonomy was developed aiming at systematizing definitions and operationalizations of medication adherence. Its translation is crucial to improve the gene...
To provide a consensus translation of the ABC taxonomy from English to Spanish....
A two-phased approach was used, according to the Preferred Methods for the Translation of the ABC Taxonomy for Medication Adherence. Two literature reviews were conducted: to identify Spanish synonyms...
Forty potential synonyms of the ABC taxonomy terms were identified from a total of 270 papers. The response rate during the first Delphi round was 32% (63/197) and in the second round 86% (54/63). A s...
The adoption of the Spanish taxonomy will increase transparency, comparability and transferability of results in the field of medication adherence. This may facilitate benchmarking of adherence strate...
Antiseizure medications (ASM) effectively prevent seizures in about 70% of adult epilepsy patients, but nonadherence to medication is the primary cause of breakthrough seizures, accounting for 26% to ...
The study involved a retrospective chart review of adult epilepsy patients seen at the University of Illinois Hospital between December 2016 and April 2020. Data on patient demographics, epilepsy and ...
The study enrolled a total of 286 adult epilepsy patients who met the eligibility criteria. Among them, 111 patients (38.81 %) were classified as nonadherent based on ASM levels. Caucasian/white race ...
More than a third of our patients were found to be non-adherent during routine follow-up visits. Lower socio-economic status and lower education were associated with increased chances of being non adh...
Poor adherence reduces the effectiveness of osteoporosis treatment, resulting in lower bone mineral density and subsequently higher fracture rates. Reliable and practical tools are needed to measure m...
Medication non-adherence is currently estimated to have caused at least 100 000 preventable deaths and over $100 billion in preventable medical costs. Adherence is particularly poor in dermatological ...
The sources of bias in medication adherence research have not been comprehensively explored. We aimed to identify biases expected to affect adherence research and to develop a framework for mapping th...
Different questionnaires assess self-reported medication adherence and others quantify aspects of patients attitudes towards medication, but not together in a single instrument. Gathering these two as...
The aim of this study was to develop the Medication Adherence Universal Questionnaire (MAUQ) using the Maastricht Utrecht Adherence in Hypertension short version (MUAH-16) factorial structure as the h...
A multistep process started with the modification of the MUAH-16 to obtain the MAUQ. Patients using at least one antihypertensive medicine were recruited. The two questionnaires, the MUAH-16 and MAUQ,...
A sample of 300 hypertensive patients completed the instruments. The CFA with the second-order 4-factor solution resulted in similar results for the MUAH-16 and MAUQ: CFIs of 0.934 and 0.930, RMSEAs o...
CFA demonstrated that the MAUQ presented a better fit to both models than the MUAH-16, obtaining a robust universal free instrument to assess medicine-taking behaviour and four medicine beliefs compon...
Anti-seizure medications (ASMs) are the primary therapeutic mode to control seizures in patients with epilepsy. Adherence to the medications is critical to achieving the goals of epilepsy therapy. How...
To assess whether self-reported availability and affordability of Anti-seizure medications affect medication adherence among Epileptic Patients at Eka Kotebe General Hospital, Addis Ababa, Ethiopia, f...
A hospital-based analytical cross-sectional study was conducted among 357 epileptic patients using the Consecutive sampling method in Eka Kotebe General Hospital, Addis Ababa, Ethiopia. ASM adherence ...
The prevalence of ASM adherence was 55.2% with 95% CI (50.1%; 60.2%). About two-thirds (61.3%) of patients in this study had limited access to the ASMs or could not afford the medications. Self-report...
Only about half of the epileptic patients adhered to ASMs at Eka Kotebe General Hospital. Self-reported availability of ASMs was an essential factor. Improving access to ASMs is critical to improving ...
We assessed the relationship of epilepsy illness perceptions to antiseizure medication (ASM) adherence....
Surveys were completed by 644 adult patients with epilepsy of unknown cause. We used the Morisky Medication Adherence Scale-8 (MMAS-8) to define "high" adherence (score = 8) and "low-medium" adherence...
One hundred forty-nine patients (23%) gave responses indicating high adherence. In the adjusted models, for each 1-unit increase in participants' BIPQ item scores, the odds of high adherence increased...
These results indicate that a greater perceived understanding of epilepsy is independently associated with high ASM adherence. Programs aimed at improving patients' understanding of their epilepsy may...